
Visceral leishmaniasis (VL), also known as kala-azar, is a neglected vector-borne disease caused by a protozoan parasite, Leishmania donovani and is transmitted by the…
Read more »Visceral leishmaniasis (VL), also known as kala-azar, is a neglected vector-borne disease caused by a protozoan parasite, Leishmania donovani and is transmitted by the…
Read more »Visceral leishmaniasis, also known as kala-azar, is a neglected vector-borne disease caused by a protozoan parasite, Leishmania donovani and is transmitted by the bite of…
Read more »Visceral Leishmaniasis is one of the neglected tropical diseases and a major global threat for health worldwide. It poses a major health problem in the poverty-ridden state of…
Read more »Visceral leishmaniasis (VL), also known as kala-azar, remains one of the most neglected diseases in Bangladesh with an estimated 65 million people at risk of the disease. Widely available, safe, and affordable therapies for…
Read more »By: Dr. Swapan Samanta
A few months back, a 9-year-old boy presented with chronic ill-health, loss of appetite, loss of weight, severe anemia, mild thrombocytopenia and occasional fever. He also had hepatosplenomegaly. A routine hemogram reported…
The skin condition post Kala-azar dermal leishmaniasis (PKDL) usually develops following treatment for visceral leishmaniasis (VL), which is caused by the protozoa Leishmania donovani. Although cases of PKDL have been described in patients not previously diagnosed with or treated for VL, up to 10% of patients with VL in the Indian subcontinent go onto develop PKDL following treatment for symptomatic VL [1].
Read more »
Asymptomatic leishmaniasis in kala-azar endemic areas of Malda district, West Bengal, India
Visceral leishmaniasis is a vector-borne protozoal disease caused by the Leishmania donovani species complex. Estimated 200,000–400,000 new cases are recorded per year worldwide of which 67% of the total cases are contributed by three Asian countries…
Read more »